Insider Trading Activity For National Health Investors, Inc. (NYSE:NHI)
Robert A Mccabe Jr , Director of National Health Investors, Inc. (NYSE:NHI) reportedly Bought 259 shares of the company’s stock at an average price of 79.94 for a total transaction amount of $20,704.46 SEC Form
Insider Trading History For National Health Investors, Inc. (NYSE:NHI)
Analyst Ratings For National Health Investors, Inc. (NYSE:NHI)
These are 1 Sell Rating, 3 Hold Ratings, 2 Buy Ratings .
The current consensus rating for National Health Investors, Inc. (NYSE:NHI) is Hold (Score: 2.17) with a consensus target price of $79.25 , a potential (0.28% downside)
Analyst Ratings History For National Health Investors, Inc. (NYSE:NHI)
- On 3/30/2016 BMO Capital Markets Boost Price Target of rating Outperform with a price target of $65.00 to $69.00
- On 6/4/2016 JMP Securities Reiterated Rating Hold
- On 9/4/2016 Wells Fargo & Company Reiterated Rating Hold
- On 9/14/2016 Stephens Initiated Coverage of rating Overweight with a price target of $84.00
- On 2/21/2017 Cantor Fitzgerald Reiterated Rating Neutral with a price target of $75.00
- On 5/22/2017 Bank of America Corporation Downgraded rating Neutral to Underperform with a price target of $76.00
- On 6/21/2017 Stifel Nicolaus Boost Price Target of rating Buy with a price target of $80.00 to $82.00
Dividend Information For National Health Investors, Inc. (NYSE:NHI)
National Health Investors, Inc. (NYSE:NHI) pays an annual dividend of Community Ranking: with a yield of 4.78% and an average dividend growth of 7.80% (3 Year Average).
Dividend History For National Health Investors, Inc. (NYSE:NHI)
Recent Trading Activity for National Health Investors, Inc. (NYSE:NHI)
Shares of National Health Investors, Inc. closed the previous trading session at 79.47 down -0.21 -0.26% with 206,289 shares trading hands.